Table 2. The RA-related pathways based on gene expression dataset (FDR<0.05).
Pathway ID | Pathway name | P-value | FDR | Function class |
---|---|---|---|---|
hsa04062 | *Chemokine signaling pathway | 0 | 0 | Organismal Systems; Immune system |
hsa04145 | *Phagosome | 0 | 0 | Cellular Processes; Transport and catabolism |
hsa04514 | *Cell adhesion molecules (CAMs) | 0 | 0 | Environmental Information Processing; Signaling molecules and interaction |
hsa04612 | *Antigen processing and presentation | 0 | 0 | Organismal Systems; Immune system |
hsa04640 | *Hematopoietic cell lineage | 0 | 0 | Organismal Systems; Immune system |
hsa04650 | *Natural killer cell mediated cytotoxicity | 0 | 0 | Organismal Systems; Immune system |
hsa04672 | *Intestinal immune network for IgA production | 0 | 0 | Organismal Systems; Immune system |
hsa04940 | *Type I diabetes mellitus | 0 | 0 | Human Diseases; Endocrine and metabolic diseases |
hsa05140 | *Leishmaniasis | 0 | 0 | Human Diseases; Infectious diseases |
hsa05150 | *Staphylococcus aureus infection | 0 | 0 | Human Diseases; Infectious diseases |
hsa05152 | *Tuberculosis | 0 | 0 | Human Diseases; Infectious diseases |
hsa05162 | *Measles | 0 | 0 | Human Diseases; Infectious diseases |
hsa05168 | *Herpes simplex infection | 0 | 0 | Human Diseases; Infectious diseases |
hsa05320 | *Autoimmune thyroid disease | 0 | 0 | Human Diseases; Immune diseases |
hsa05323 | *Rheumatoid arthritis | 0 | 0 | Human Diseases; Immune diseases |
hsa05330 | *Allograft rejection | 0 | 0 | Human Diseases; Immune diseases |
hsa05332 | *Graft-versus-host disease | 0 | 0 | Human Diseases; Immune diseases |
hsa05340 | Primary immunodeficiency | 0 | 0 | Human Diseases; Immune diseases |
hsa05416 | *Viral myocarditis | 0 | 0 | Human Diseases; Cardiovascular diseases |
hsa04660 | *T cell receptor signaling pathway | 1.00E-05 | 9.95E-05 | Organismal Systems; Immune system |
hsa05310 | *Asthma | 2.00E-05 | 0.000181 | Human Diseases; Immune diseases |
hsa05164 | *Influenza A | 2.00E-05 | 0.000189 | Human Diseases; Infectious diseases |
hsa04662 | B cell receptor signaling pathway | 4.00E-05 | 0.000346 | Organismal Systems; Immune system |
hsa04666 | Fc gamma R-mediated phagocytosis | 5.00E-05 | 0.000414 | Organismal Systems; Immune system |
hsa05145 | *Toxoplasmosis | 9.00E-05 | 0.000716 | Human Diseases; Infectious diseases |
hsa04620 | Toll-like receptor signaling pathway | 0.00011 | 0.000842 | Organismal Systems; Immune system |
hsa04380 | Osteoclast differentiation | 0.00014 | 0.001031 | Organismal Systems; Development |
hsa04142 | Lysosome | 0.00244 | 0.017334 | Cellular Processes; Transport and catabolism |
hsa03030 | *DNA replication | 0.00326 | 0.021616 | Genetic Information Processing; Replication and repair |
hsa05110 | Vibrio cholerae infection | 0.00317 | 0.021744 | Human Diseases; Infectious diseases |
hsa04670 | *Leukocyte transendothelial migration | 0.00431 | 0.027656 | Organismal Systems; Immune system |
hsa04110 | *Cell cycle | 0.00521 | 0.032386 | Cellular Processes; Cell growth and death |
hsa04664 | Fc epsilon RI signaling pathway | 0.00778 | 0.046896 | Organismal Systems; Immune system |
Pathways were reported as RA-related pathways in previous literatures.
Italic pathways were also detected based on GWAS.